X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (26989) 26989
Book Review (3709) 3709
Publication (834) 834
Book / eBook (362) 362
Magazine Article (47) 47
Book Chapter (27) 27
Newsletter (26) 26
Conference Proceeding (24) 24
Dissertation (9) 9
Web Resource (5) 5
Newspaper Article (2) 2
Reference (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25537) 25537
index medicus (24663) 24663
male (17096) 17096
female (13599) 13599
middle aged (12686) 12686
aged (12489) 12489
urinary bladder neoplasms - surgery (11659) 11659
urinary bladder neoplasms - pathology (8262) 8262
urology & nephrology (7903) 7903
adult (7294) 7294
cancer (5514) 5514
bladder cancer (5280) 5280
oncology (4739) 4739
aged, 80 and over (4630) 4630
cystectomy (4216) 4216
abridged index medicus (4188) 4188
treatment outcome (3752) 3752
prognosis (3582) 3582
carcinoma, transitional cell - surgery (3525) 3525
surgery (3453) 3453
retrospective studies (3364) 3364
follow-up studies (3332) 3332
neoplasm staging (3089) 3089
urology (3028) 3028
carcinoma (2996) 2996
carcinoma, transitional cell - pathology (2826) 2826
urinary bladder neoplasms - drug therapy (2823) 2823
urinary bladder neoplasms - mortality (2553) 2553
bladder (2496) 2496
urinary bladder neoplasms - diagnosis (2402) 2402
tumors (2252) 2252
cystectomy - methods (2248) 2248
urinary bladder neoplasms - therapy (2247) 2247
urinary bladder - surgery (2229) 2229
neoplasm invasiveness (2218) 2218
care and treatment (2204) 2204
radical cystectomy (2108) 2108
time factors (1929) 1929
risk factors (1892) 1892
combined modality therapy (1879) 1879
chemotherapy (1878) 1878
prostatic neoplasms - surgery (1861) 1861
analysis (1826) 1826
urinary diversion (1700) 1700
survival (1697) 1697
transitional-cell carcinoma (1573) 1573
urothelial carcinoma (1562) 1562
research (1550) 1550
diagnosis (1543) 1543
recurrence (1478) 1478
medicine & public health (1465) 1465
survival rate (1452) 1452
urinary bladder (1437) 1437
urinary bladder neoplasms - radiotherapy (1414) 1414
urinary-bladder (1398) 1398
prospective studies (1376) 1376
urinary bladder - pathology (1369) 1369
urinary bladder neoplasms (1350) 1350
animals (1313) 1313
health aspects (1303) 1303
pathology (1278) 1278
urinary bladder neoplasms - genetics (1272) 1272
radiotherapy (1224) 1224
postoperative complications (1203) 1203
prostatectomy (1181) 1181
immunohistochemistry (1178) 1178
disease-free survival (1166) 1166
antineoplastic combined chemotherapy protocols - therapeutic use (1144) 1144
urinary diversion - methods (1144) 1144
carcinoma, transitional cell - mortality (1139) 1139
prostate cancer (1131) 1131
bladder-cancer (1107) 1107
neoplasm recurrence, local (1106) 1106
cystoscopy (1105) 1105
urinary bladder neoplasms - metabolism (1073) 1073
metastasis (1035) 1035
carcinoma, transitional cell - drug therapy (1030) 1030
complications (1026) 1026
lymphatic metastasis (1010) 1010
transitional-cell-carcinoma (1006) 1006
administration, intravesical (991) 991
therapy (984) 984
urinary bladder neoplasms - complications (981) 981
ureter - surgery (976) 976
quality of life (956) 956
methods (955) 955
radiology, nuclear medicine & medical imaging (954) 954
outcomes (949) 949
expression (926) 926
management (914) 914
risk (913) 913
experience (910) 910
survival analysis (909) 909
adolescent (904) 904
prostatic neoplasms - pathology (894) 894
chemotherapy, adjuvant (884) 884
diagnosis, differential (881) 881
disease progression (854) 854
tomography, x-ray computed (845) 845
prostate (837) 837
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (295) 295
Collection Dvlpm't (Acquisitions) - Closed Orders (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (12) 12
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (12) 12
Online Resources - Online (9) 9
Scarborough Hospital - General (6) 6
Holland Bloorview Kids Rehabilitation - Stacks (5) 5
St. Michael's Hospital - Stacks (5) 5
Humber River Regional Hospital - Church Stacks (3) 3
Providence Healthcare - Reference (3) 3
Toronto East General Hospital - Stacks (3) 3
Baycrest Hospital - Stacks (2) 2
Credit Valley Hospital - Reference (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Providence Healthcare - Stacks (2) 2
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Not Returned (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
Providence Healthcare - Reserve desk (1) 1
Scarborough Hospital - Birchmount (1) 1
Toronto East General Hospital - Online (1) 1
Trillium Health Centre - Stacks (1) 1
UofT Schools - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
West Park Healthcare Centre - Hospital Department (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (22764) 22764
Japanese (980) 980
German (953) 953
French (847) 847
Spanish (563) 563
Russian (361) 361
Chinese (298) 298
Italian (287) 287
Polish (72) 72
Bulgarian (57) 57
Hungarian (40) 40
Danish (36) 36
Dutch (32) 32
Czech (29) 29
Romanian (29) 29
Portuguese (22) 22
Hebrew (18) 18
Swedish (18) 18
Norwegian (17) 17
Croatian (13) 13
Turkish (12) 12
Slovak (9) 9
Serbian (7) 7
Ukrainian (5) 5
Lithuanian (4) 4
Afrikaans (3) 3
Finnish (3) 3
Korean (3) 3
Arabic (2) 2
Bosnian (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 76 - 86
Summary Background Patients with muscle-invasive urothelial carcinoma of the bladder have poor survival after cystectomy. The EORTC 30994 trial aimed to... 
Hematology, Oncology and Palliative Medicine | ADJUVANT CHEMOTHERAPY | PLUS CISPLATIN | METAANALYSIS | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | DOXORUBICIN | METHOTREXATE | VINBLASTINE | CANCER | III TRIAL | GEMCITABINE | Lymph Node Excision | Cystectomy - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma - mortality | Male | Vinblastine - administration & dosage | Cystectomy - adverse effects | Urothelium - pathology | Cisplatin - administration & dosage | Time Factors | Urinary Bladder Neoplasms - pathology | Female | Chemotherapy, Adjuvant | Carcinoma - pathology | Doxorubicin - administration & dosage | Carcinoma - drug therapy | Urinary Bladder Neoplasms - mortality | Drug Administration Schedule | Time-to-Treatment | Carcinoma - surgery | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Urinary Bladder Neoplasms - surgery | Canada | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Methotrexate - administration & dosage | Urothelium - surgery | Neoplasm Staging | Urothelium - drug effects | Deoxycytidine - analogs & derivatives | Care and treatment | Chemotherapy | Carcinoma | Hospitals | Cancer | Index Medicus
Journal Article
The Journal of urology, ISSN 0022-5347, 07/2019, Volume 202, Issue 1, pp. 30 - 31
Journal Article
Cancer, ISSN 0008-543X, 11/2017, Volume 123, Issue 22, pp. 4346 - 4355
When evaluating the impact of neoadjuvant chemotherapy before radical cystectomy for patients with nonpure urothelial histological variants, only those... 
cystectomy | neoadjuvant chemotherapy | neoplasms by histologic type | urinary bladder neoplasms | survival | UROTHELIAL CARCINOMA | DOXORUBICIN | PATHOLOGICAL RESPONSE | VINBLASTINE | PREOPERATIVE CHEMOTHERAPY | CISPLATIN | ONCOLOGY | SMALL-CELL CARCINOMA | ACCELERATED METHOTREXATE | DIFFERENTIATION | OUTCOMES | Carcinoma, Transitional Cell - epidemiology | Cystectomy - statistics & numerical data | Humans | Middle Aged | Male | Urinary Bladder Neoplasms - pathology | Adult | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Muscle Neoplasms - drug therapy | Urinary Bladder Neoplasms - epidemiology | Databases, Factual | Muscle Neoplasms - surgery | Neoplasm Invasiveness | Muscle Neoplasms - secondary | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Urinary Bladder Neoplasms - surgery | Muscle Neoplasms - epidemiology | Carcinoma, Transitional Cell - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Transitional Cell - drug therapy | Aged | Carcinoma, Transitional Cell - surgery | Cystectomy - methods | Cancer patients | Chemotherapy | Usage | Cystectomy | Diagnosis | Bladder cancer | Health aspects | Cancer | Adenocarcinoma | Urothelial cancer | Squamous cell carcinoma | Statistical analysis | Identification methods | Invasiveness | Differentiation (biology) | Bladder | Histology | Regression analysis | Patients | Survival | Confidence intervals | Regression models | Urinary bladder | Biopsy | Urothelial carcinoma | Tumors | Neuroendocrine tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 11/2017, Volume 123, Issue 22, pp. 4337 - 4345
In the National Cancer Data Base, the receipt of bladder‐preservation therapy appears to be associated with decreased overall survival compared with treatment... 
survival analyses | chemoradiotherapy | radical cystectomy | bladder‐preservation therapy | muscle‐invasive bladder cancer | temporal trends | muscle-invasive bladder cancer | bladder-preservation therapy | UNITED-STATES | PROPENSITY SCORE | UROTHELIAL CARCINOMA | LONG-TERM OUTCOMES | CHEMOTHERAPY | METHODOLOGY | ONCOLOGY | MODALITY THERAPY | OF-THE-LITERATURE | DATA-BASE | TRIMODAL THERAPY | Carcinoma, Transitional Cell - mortality | Cystectomy - mortality | Abdominal Neoplasms - secondary | Cystectomy - statistics & numerical data | Humans | Middle Aged | Male | Chemoradiotherapy | Muscle Neoplasms - mortality | Organ Sparing Treatments - trends | Urinary Bladder Neoplasms - pathology | Adult | Female | Databases, Factual | Urinary Bladder Neoplasms - mortality | Muscle Neoplasms - surgery | Neoplasm Invasiveness | Muscle Neoplasms - secondary | Treatment Outcome | Urinary Bladder Neoplasms - surgery | Abdominal Neoplasms - surgery | Carcinoma, Transitional Cell - pathology | Abdominal Neoplasms - mortality | Abdominal Muscles - pathology | Survival Analysis | Organ Sparing Treatments - statistics & numerical data | Aged | Cystectomy - trends | Carcinoma, Transitional Cell - surgery | Organ Sparing Treatments - mortality | Neoplasm Staging | Cystectomy - methods | Cystectomy | Usage | Care and treatment | Cancer patients | Chemotherapy | Diagnosis | Bladder cancer | Health aspects | Cancer | Statistical analysis | Preservation | Identification methods | Invasiveness | String matching | Bladder | Statistical methods | Radiation therapy | Criteria | Regression analysis | Cancer therapies | Patients | Survival | Data bases | Confidence intervals | Databases | Statistical models | Urinary bladder | Attenuation | Mathematical models | Trends | Urothelial carcinoma | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2012, Volume 63, Issue 3, pp. 462 - 472
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 8/2007, Volume 56, Issue 8, pp. 1173 - 1182
The programmed death-1 (PD-1)/B7-H1 (also called PD-L1) pathway negatively regulates T cell activation and has been suggested to play an important role in... 
Urothelial cancer | Biomedicine | Immunology | B7-H1/PD-L1 | Costimulation | T cell | Oncology | Cancer Research | Antitumor immunity | PD-1 | BLADDER-CANCER | DENDRITIC CELLS | PROGRAMMED DEATH-1 | urothelial cancer | TISSUE INFILTRATING LYMPHOCYTES | IMMUNOLOGY | antitumor immunity | POTENTIAL MECHANISM | RENAL-CELL CARCINOMA | CD8(+) T-CELLS | costimulation | ONCOLOGY | PD-L1 | B7 FAMILY | B7-H1 | EXPRESSION | Carcinoma, Transitional Cell - mortality | Prognosis | Antigens, CD - biosynthesis | Humans | Neoplasm Proteins - physiology | Gene Expression Regulation, Neoplastic | Kidney Pelvis - chemistry | Ureteral Neoplasms - pathology | Male | Kidney Neoplasms - chemistry | Antigens, CD - genetics | Antigens, CD - analysis | Kidney Neoplasms - surgery | Urinary Bladder Neoplasms - pathology | Female | Neoplasm Proteins - genetics | Kidney Pelvis - surgery | Urinary Bladder Neoplasms - mortality | B7-H1 Antigen | Neoplasm Proteins - biosynthesis | Ureteral Neoplasms - chemistry | Neoplasm Recurrence, Local | Proportional Hazards Models | Kidney Pelvis - pathology | Immunophenotyping | Kidney Neoplasms - mortality | Urinary Bladder Neoplasms - surgery | Carcinoma, Transitional Cell - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Carcinoma, Transitional Cell - chemistry | Survival Analysis | Antigens, CD - physiology | Kidney Neoplasms - pathology | Neoplasm Proteins - analysis | Urinary Bladder Neoplasms - chemistry | Carcinoma, Transitional Cell - surgery | Ureteral Neoplasms - mortality | Ureteral Neoplasms - surgery | Lymphocytes, Tumor-Infiltrating - immunology | Cancer | Index Medicus
Journal Article